Skip to content
Government Federal, Medical Health Aged Care

Delving into diabetes

House of Representatives 2 mins read

The broader impacts of diabetes on Australia’s health system and economy, and recent advances in the prevention and management of this significant health condition, will be the focus of a new inquiry by the House Health Committee.

The Chair of the Committee, Dr Mike Freelander MP, stated: ‘Diabetes is the world’s fastest growing chronic health condition, currently impacting approximately 1.3 million Australians. There are multiple forms of diabetes, including type 1, type 2, gestational and other rare types. The Committee looks forward to conducting this inquiry to better understand the current situation regarding diabetes in Australia, including the effectiveness of current Australian Government policies and programs aiming to prevent, diagnose and manage the condition.’

‘The Inquiry will be broad and will also look at lifestyle factors and the interaction between lifestyle, Type 2 diabetes, and obesity’ stated Dr Freelander.

‘The Committee looks forward to hearing from individuals with diabetes, healthcare service providers, researchers, peak bodies, the Australian Government, state and territory governments and members of the public to understand new evidence-based advances in the prevention and management of the condition, and the broader impacts of diabetes on Australia’s health system and economy’ he said.

Submissions from interested individuals and organisations are invited by 31 August 2023. The preferred method of receiving submissions is by electronic format lodged online using a My Parliament account.

Further information about the Committee’s inquiry, including the full terms of reference and details on how to lodge a submission are available at the Committee’s website.

Media inquiries

Dr Mike Freelander MP
Chair of the House of Representatives Standing Committee on Health, Aged Care and Sport
[email protected]
(02) 4620 0293

For background information

Committee Secretariat
02 6277 4145
[email protected]



More from this category

  • Medical Health Aged Care, Women
  • 04/03/2026
  • 06:00
Australia New Zealand Gynaecological Oncology Group (ANZGOG)

STRIVE clinical trial now available in Aotearoa New Zealand to improve outcomes in vulvar cancer

MEDIA RELEASE: Wednesday,4March2025 The Australian New Zealand Gynaecological Oncology Group (ANZGOG) in partnership with the Canadian Cancer Trials Group (CCTG) announces the local opening of theSTRIVEclinical trial– Stratification of Vulvar Squamous Cell Carcinoma by HPV and p53 status to Guide Excisionclinical trial (CCTG Protocol VU.2; ANZGOG Protocol ANZGOG2109/2021). STRIVErepresentsan important stepforward in advancing evidence-based surgical management for women diagnosed with vulvar squamous cell carcinoma (VSCC). About the STRIVE Trial STRIVE is an international, prospective, stratification study designed to refine surgical decision-making for patients withprimary vulvar squamous cell carcinoma(VSCC) based ontumourbiology. The study is led globally by the CCTG and led…

  • Government Federal, Mental Health
  • 04/03/2026
  • 04:00
Royal Australian and New Zealand College of Psychiatrists

Budget action needed to tackle Australia’s mental health crisis

WEDNESDAY 4 MARCH 2026 Budget action needed to tackle Australia’s mental health crisis Australia has only 16 psychiatrists for every 100,000 people, with forecast shortages of 20 per cent for decades to come Regional Australia and young people have been hit hardest by workforce shortages Training the next generation to meet demand can avert a worsening crisis, and would cost less than a dollar per Australian. Psychiatrists on the front lines of Australia’s mental health system have called for smart, targeted and urgent investment in specialist training in the May budget so people can access affordable mental health treatment, especially…

  • Medical Health Aged Care
  • 03/03/2026
  • 21:26
SAV-IOL

Lucidis® Sets High Standards in Premium Cataract Surgery with Full-Range Vision Performance

NEUCHÂTEL, Switzerland–BUSINESS WIRE– Swiss Advanced Vision announces new clinical evidence confirming the exceptional performance of its Lucidis® intraocular lens (IOL), strengthening its position as…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.